67 results on '"Detlefsen, Sönke"'
Search Results
2. SAT-266 Fibrosis stage progression in alcohol-related liver disease evaluated by repeated biopsies
3. WED-199 Optimizing MASLD trial recruitment: LiverPRO vs. FIB-4 in reducing false positives and unnecessary biopsies
4. OS-041-YI A spatiotemporal map of the hepatocyte proteome in alpha-1 antitrypsin deficiency by single-cell and visual proteomics
5. Adaptive MRI-guided stereotactic body radiation therapy for locally advanced pancreatic cancer – A phase II study
6. Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology
7. Infections Increase The Risk Of Decompensation And Death In Patients With Early Alcohol-Related Liver Disease
8. LiverPRO for the Prediction of Significant Liver Fibrosis in Primary Care: Development, Validation, and Prognostic Evaluation of a Novel Score
9. Prognostic value of margin clearance in total and distal pancreatectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study
10. High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgically treated pancreatic ductal adenocarcinoma
11. Screening for fibrosis promotes life-style changes. A prospective cohort study in 4,796 individuals
12. Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module
13. Prognostic importance of margin clearance in ampullary adenocarcinoma following pancreaticoduodenectomy in a Danish population-based nationwide study
14. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
15. Health-related quality of life in a population at-risk of NAFLD or ArLD
16. Soluble TREM2 and PRO-C3 as efficacy of intervention markers in NASH
17. Clinical course of biopsy-controlled alcohol-related liver disease
18. Cardiovascular events in patients with alcohol-related liver disease and the prognostic value of endotrophin assessed by PRO-C6
19. A cost-comparison of the LiverPRO score with FIB-4, ELF, and FibroScan in 6,032 study participants
20. Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
21. Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
22. SPHINGOLIPIDS ARE DEPLETED IN ALCOHOL-RELATED LIVER FIBROSIS
23. Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163
24. Pd-L1 Blockade Followed by Irreversible Electroporation of a Liver Metastasis in Pancreatic Cancer Patients
25. Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis
26. Single-cell dynamics of interacting mesenchymal and leukocyte populations in advanced NASH
27. The LiverPRO score, a multivariable model for prediction of significant fibrosis in primary care: derivation, validation and comparison with FIB-4 and ELF-test in 5, 000 study participants
28. A non-calorie restricted low carbohydrate high fat diet improves non-alcoholic fatty liver disease (NAFLD) activity score (NAS) and HbA1c in type 2 diabetes: a six-month randomised controlled trial
29. Plasma TREM2, a novel non-invasive biomarker for diagnosis of NASH in NAFLD patients with elevated liver stiffness
30. Anti-fibrotic effect of rifaximin in early alcohol-related liver disease: a double-blind, randomised, placebo-controlled trial
31. Infections are common in patients with early alcohol-related liver disease and increases the risk of death
32. Serologically assessed heat shock protein 47 is related to fibrosis stage in early compensated alcohol-related liver disease
33. Tu1197: WHOLE GENOME SEQUENCING IDENTIFIES RARE GENETIC VARIANTS IN FAMILIAL PANCREATIC CANCER PATIENTS
34. Stage-dependent expression of fibrogenic markers in alcohol-related liver disease
35. Role of immunohistochemistry for interobserver agreement of Peritoneal Regression Grading Score in peritoneal metastasis
36. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
37. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes
38. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease
39. Synchronous detection of pancreatic adenocarcinoma and paraganglioma in a Whipple resection specimen
40. Su293 HERITABILITY OF FAMILIAL PANCREATIC CANCER IN A DANISH NATIONAL FAMILY COHORT
41. Su291 WHOLE GENOME SEQUENCING OF FIRST-DEGREE RELATIVES OF PATIENTS WITH FAMILIAL PANCREATIC CANCER IDENTIFIES GENES AND FUNCTIONAL PATHWAYS ENRICHED IN RARE GENETIC VARIANTS
42. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens
43. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm
44. Sialadenitis in a patient with ulcerative colitis and autoimmune pancreatitis type 2
45. Metabolic and genetic risk factors predict advanced alcohol-related liver fibrosis regardless of drinking pattern
46. Pancreatic neuroendocrine tumors with somatostatin expression and paraganglioma-like features
47. Synchronous detection of SDHA-related gallbladder paraganglioma and pancreatic neuroendocrine tumor
48. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma
49. Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma
50. Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.